Compounds > inogatran
Page last updated: 2024-08-24

inogatran and Coronary Disease

inogatran has been researched along with Coronary Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grip, L; Linder, R; Nørgaard, BL; Oldgren, J; Siegbahn, A; Wallentin, L1
Heickendorff, L; Lüscher, MS; Ravkilde, J; Thygesen, K1
Antman, EM1
Abrahamsson, P; Andersen, K; Clemmensen, P; Dellborg, M; Grande, P; Holmvang, L; Wagner, G1
Fischer-Hansen, J; Grip, L; Gundersen, T; Lehto, S; Näslund, U; Wallentin, L1
Abrahamsson, P; Andersen, K; Dellborg, M; Nørgaard, BL; Ravkilde, J; Thygesen, K1
Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Wallentin, L1

Trials

6 trial(s) available for inogatran and Coronary Disease

ArticleYear
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
    European heart journal, 2003, Volume: 24, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antithrombins; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Piperidines; Survival Analysis; Troponin T

2003
Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia.
    Circulation, 1997, Oct-21, Volume: 96, Issue:8

    Topics: Adult; Aged; Antithrombins; Cohort Studies; Coronary Disease; Female; Glycine; Heparin; Humans; Male; Middle Aged; Multivariate Analysis; Myocardium; Outcome Assessment, Health Care; Piperidines; Prognosis; Prospective Studies; Troponin; Troponin I; Troponin T

1997
Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease.
    The American journal of cardiology, 1999, Mar-01, Volume: 83, Issue:5

    Topics: Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Antithrombins; Coronary Disease; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Glycine; Heparin; Humans; Hypertension; Male; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Patient Admission; Piperidines; Prognosis; Recurrence; Risk Assessment; Risk Factors; Survival Rate; Vectorcardiography

1999
The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points.
    European heart journal, 1999, Volume: 20, Issue:10

    Topics: Anticoagulants; Antithrombins; Coronary Disease; Data Collection; Double-Blind Method; Glycine; Heparin; Humans; Multicenter Studies as Topic; Outcome Assessment, Health Care; Piperidines; Randomized Controlled Trials as Topic; Survival Analysis

1999
Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Antithrombins; Coronary Disease; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Patient Admission; Piperidines; Prognosis; Prospective Studies; Risk Assessment; Troponin T; Vectorcardiography

1999
Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
    European heart journal, 1999, Volume: 20, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Antithrombins; Cause of Death; Coronary Disease; Dose-Response Relationship, Drug; Female; Glycine; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Piperidines; Survival Rate; Thrombin; Treatment Outcome

1999

Other Studies

1 other study(ies) available for inogatran and Coronary Disease

ArticleYear
Another chapter of the antithrombin story has been written...
    European heart journal, 1997, Volume: 18, Issue:9

    Topics: Acute Disease; Antithrombins; Coronary Disease; Glycine; Heparin; Hirudin Therapy; Humans; Piperidines; Syndrome

1997